NCT05630573View on ClinicalTrials.gov

A Study of TNM001 in Chinese Healthy Preterm and Term Infants

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

October 25, 2022

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Respiratory Syncytial Virus Infections
Interventions
BIOLOGICAL

TNM001

intramuscular injection

BIOLOGICAL

Placebo

intramuscular injection

Trial Locations (6)

410005

Hunan Provincial People's Hospital, Changsha

410006

The Third Xiangya Hospital of Central South University, Changsha

610041

West China Second University Hospital, Sichuan University, Chengdu

050000

The Second Hospital of Hebei Medical University, Shijiazhuang

041000

Linfen People's Hospital, Linfen

044099

Yuncheng Central Hospital, Yuncheng

All Listed Sponsors
lead

Zhuhai Trinomab Pharmaceutical Co., Ltd.

INDUSTRY